Literature DB >> 22242662

Synergistic interactions between chemokine receptor elements in recognition of interleukin-8 by soluble receptor mimics.

Emily F Barter1, Martin J Stone.   

Abstract

Interleukin-8 (IL-8 or CXCL8), the archetypal member of the CXC chemokine subfamily, stimulates neutrophil chemotaxis by activating receptors CXCR1/IL8RA and CXCR2/IL8RB. Previous mutational studies have implicated both the N-terminal and third extracellular loop (E3) regions of these receptors in binding to IL-8. To investigate the interactions of these receptor elements with IL-8, we have constructed soluble proteins in which the N-terminal and E3 elements of either CXCR1 or CXCR2 are juxtaposed on a soluble scaffold protein; these are termed CROSS-N(X1)E3(X1) and CROSS-N(X2)E3(X2), respectively. Isothermal titration calorimetry and nuclear magnetic resonance spectroscopy were used to compare the IL-8 binding properties of the receptor mimics to those of control proteins containing only the N-terminal or E3 receptor element. CROSS-N(X2)E3(X2) bound to monomeric IL-8 with the same affinity and induced the same chemical shift changes as the control protein containing only the N-terminal element of CXCR2, indicating that the E3 element of CXCR2 did not contribute to IL-8 binding. In contrast, CROSS-N(X1)E3(X1) bound to IL-8 with ~10-fold increased affinity and induced different chemical shift changes compared to the control protein containing only the N-terminal element of CXCR1, suggesting that the E3 region of CXCR1 was interacting with IL-8. However, a chimeric protein containing the N-terminal region of CXCR1 and the E3 region of CXCR2 (CROSS-N(X1)E3(X2)) bound to IL-8 with thermodynamic properties and induced chemical shift changes indistinguishable from those of CROSS-N(X1)E3(X1) and substantially different from those of CROSS-N(X2)E3(X2). These results indicate that the N-terminal and E3 regions of CXCR1 interact synergistically to achieve optimal binding interactions with IL-8.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22242662      PMCID: PMC3309041          DOI: 10.1021/bi201615y

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  30 in total

1.  1H NMR solution structure of an active monomeric interleukin-8.

Authors:  K Rajarathnam; I Clark-Lewis; B D Sykes
Journal:  Biochemistry       Date:  1995-10-10       Impact factor: 3.162

2.  NMRPipe: a multidimensional spectral processing system based on UNIX pipes.

Authors:  F Delaglio; S Grzesiek; G W Vuister; G Zhu; J Pfeifer; A Bax
Journal:  J Biomol NMR       Date:  1995-11       Impact factor: 2.835

3.  Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1.

Authors:  M P Crump; J H Gong; P Loetscher; K Rajarathnam; A Amara; F Arenzana-Seisdedos; J L Virelizier; M Baggiolini; B D Sykes; I Clark-Lewis
Journal:  EMBO J       Date:  1997-12-01       Impact factor: 11.598

4.  Complete mutagenesis of the extracellular domain of interleukin-8 (IL-8) type A receptor identifies charged residues mediating IL-8 binding and signal transduction.

Authors:  S R Leong; R C Kabakoff; C A Hébert
Journal:  J Biol Chem       Date:  1994-07-29       Impact factor: 5.157

5.  Partial functional mapping of the human interleukin-8 type A receptor. Identification of a major ligand binding domain.

Authors:  C A Hébert; A Chuntharapai; M Smith; T Colby; J Kim; R Horuk
Journal:  J Biol Chem       Date:  1993-09-05       Impact factor: 5.157

6.  Structural requirements for interleukin-8 function identified by design of analogs and CXC chemokine hybrids.

Authors:  I Clark-Lewis; B Dewald; M Loetscher; B Moser; M Baggiolini
Journal:  J Biol Chem       Date:  1994-06-10       Impact factor: 5.157

7.  Importance of the amino terminus of the interleukin-8 receptor in ligand interactions.

Authors:  R B Gayle; P R Sleath; S Srinivason; C W Birks; K S Weerawarna; D P Cerretti; C J Kozlosky; N Nelson; T Vanden Bos; M P Beckmann
Journal:  J Biol Chem       Date:  1993-04-05       Impact factor: 5.157

8.  Neutrophil activation by monomeric interleukin-8.

Authors:  K Rajarathnam; B D Sykes; C M Kay; B Dewald; T Geiser; M Baggiolini; I Clark-Lewis
Journal:  Science       Date:  1994-04-01       Impact factor: 47.728

9.  CXC chemokines bind to unique sets of selectivity determinants that can function independently and are broadly distributed on multiple domains of human interleukin-8 receptor B. Determinants of high affinity binding and receptor activation are distinct.

Authors:  S K Ahuja; J C Lee; P M Murphy
Journal:  J Biol Chem       Date:  1996-01-05       Impact factor: 5.157

10.  Both interleukin-8 receptors independently mediate chemotaxis. Jurkat cells transfected with IL-8R1 or IL-8R2 migrate in response to IL-8, GRO alpha and NAP-2.

Authors:  P Loetscher; M Seitz; I Clark-Lewis; M Baggiolini; B Moser
Journal:  FEBS Lett       Date:  1994-03-21       Impact factor: 4.124

View more
  11 in total

1.  Solution NMR characterization of WT CXCL8 monomer and dimer binding to CXCR1 N-terminal domain.

Authors:  Prem Raj B Joseph; Krishna Rajarathnam
Journal:  Protein Sci       Date:  2014-11-28       Impact factor: 6.725

2.  Chemokine CXCL1 dimer is a potent agonist for the CXCR2 receptor.

Authors:  Aishwarya Ravindran; Kirti V Sawant; Jose Sarmiento; Javier Navarro; Krishna Rajarathnam
Journal:  J Biol Chem       Date:  2013-03-11       Impact factor: 5.157

3.  Structure of monomeric Interleukin-8 and its interactions with the N-terminal Binding Site-I of CXCR1 by solution NMR spectroscopy.

Authors:  Sabrina Berkamp; Sang Ho Park; Anna A De Angelis; Francesca M Marassi; Stanley J Opella
Journal:  J Biomol NMR       Date:  2017-11-15       Impact factor: 2.835

Review 4.  New paradigms in chemokine receptor signal transduction: Moving beyond the two-site model.

Authors:  Andrew B Kleist; Anthony E Getschman; Joshua J Ziarek; Amanda M Nevins; Pierre-Arnaud Gauthier; Andy Chevigné; Martyna Szpakowska; Brian F Volkman
Journal:  Biochem Pharmacol       Date:  2016-04-19       Impact factor: 5.858

5.  Isothermal titration calorimetry of membrane proteins - progress and challenges.

Authors:  Krishna Rajarathnam; Jörg Rösgen
Journal:  Biochim Biophys Acta       Date:  2013-06-05

6.  Interaction of Monomeric Interleukin-8 with CXCR1 Mapped by Proton-Detected Fast MAS Solid-State NMR.

Authors:  Sang Ho Park; Sabrina Berkamp; Jasmina Radoicic; Anna A De Angelis; Stanley J Opella
Journal:  Biophys J       Date:  2017-12-19       Impact factor: 4.033

7.  Peptides derived from CXCL8 based on in silico analysis inhibit CXCL8 interactions with its receptor CXCR1.

Authors:  Shinn-Jong Jiang; Je-Wen Liou; Chun-Chun Chang; Yi Chung; Lee-Fong Lin; Hao-Jen Hsu
Journal:  Sci Rep       Date:  2015-12-22       Impact factor: 4.379

8.  In silico analysis reveals sequential interactions and protein conformational changes during the binding of chemokine CXCL-8 to its receptor CXCR1.

Authors:  Je-Wen Liou; Fang-Tzu Chang; Yi Chung; Wen-Yi Chen; Wolfgang B Fischer; Hao-Jen Hsu
Journal:  PLoS One       Date:  2014-04-04       Impact factor: 3.240

9.  Heparin-bound chemokine CXCL8 monomer and dimer are impaired for CXCR1 and CXCR2 activation: implications for gradients and neutrophil trafficking.

Authors:  Prem Raj B Joseph; Kirti V Sawant; Krishna Rajarathnam
Journal:  Open Biol       Date:  2017-11       Impact factor: 6.411

10.  Dynamics-Derived Insights into Complex Formation between the CXCL8 Monomer and CXCR1 N-Terminal Domain: An NMR Study.

Authors:  Prem Raj B Joseph; Leo Spyracopoulos; Krishna Rajarathnam
Journal:  Molecules       Date:  2018-10-31       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.